In the specialized field of biochemical research, the compound often categorized under the umbrella of research chemicals is peptide anastrozole. While frequently discussed in various contexts, it is essential for researchers to understand that anastrozole is chemically defined as a non-steroidal drug that belongs to the class of aromatase inhibitors. Often identified by its CAS number 120511-73-1, this substance is a subject of significant interest in studies concerning Anastrozole - Bio-X ™ | 120511-73-1 | BT164176 enzyme inhibition and steroid biosynthesis.
Technical Profile and Chemical Classification
From a structural perspective, anastrozole is a nonsteroidal aromatase inhibitor that contains a triazole functional group. It is classified as a third-generation aromatase inhibitor, which distinguishes it from earlier iterations due to its high selectivity and potency. In laboratory settings, anastrozole is a potent, highly selective aromatase inhibitor that functions by reversibly binding to the cytochrome P-450 component of the aromatase enzyme complex.
Researchers often source this compound as a synthetic non-steroidal aromatase inhibitor (AI) designed for rigorous analytical studies. For example, when acquiring anastrozole Anastrozole 1mg per ml x 30ml solutions for experimental use, purity is a paramount concern. High-quality sources, such as those that might be found when one looks to buy anastrozole from Melanotan Express or other specialized providers, typica Peptides in breast cancer therapy: From mechanisms to emerging lly ensure at least 99% purity, which is critical for maintaining the integrity of *in vitro* enzyme inhibition assays.
Research Applications and Molecular Characteristics
The molecular formula of this compound is C17H19N5, with a molecular weight of 293.37 g/mol. Because it is a third-generation nonsteroidal selective aromatase inhibitor, it is frequently utilized in endocrine signaling research. It Anastrozole - NCI is important to note that anastrozole is a type of hormone therapy called an aromatase inhibitor that effectively blocks estrogen synthesis in specific controlled environments.
In the context of comparative research, anastrozole is a non-steroidal, selective third-generation aromatase inhibitor of the triazole structural class. Its efficacy is often demonstrated by its ability to inhibit human placental aromatase, with studies frequently citing an IC50 of approximately 15 nM. This makes it an invaluable tool for researchers aiming to understand the complexities of steroidogenesis and its modulation.
Sourcing and Laboratory St Jan 15, 2018 — Anastrozole is used with other treatments, such as surgery or radiation, to treat early breast cancer in women who have experienced menopause. andards
When procuring these research solutions, such as opting to buy Anastrozole SERM from Peptide Pros, it is standard practice to verify the analytical grade of the product. Many researchers utilize such compounds in studies related to how anastrozole is a potent, selective aromatase inhibitor for endocrine signaling.
It is a common point of confusion in public discourse that this substance is often discussed alongside medical treatments; however, in the context of professional research, it is strictly categorized as a laboratory tool. Whether one is evaluating anastrozole for its role in enzyme kinetics or its interaction with specific receptors, the focus remains on the chemical's ability to act through competitive inhib This product is for laboratory research use only and may not be used for other purposes. Sticky Image. Anastrozole 1mg per ml x 30ml. 8 0. ADD TO CART ition.
Important Considerations for Researchers
While the broader public discourse often focuses on how anastrozole is commonly used to treat certain types of breast cancer or how it is used to treat early hormone receptor-positive breast cancer, these applications are strictly within the clinical and medical domain. In contrast, the inves What is Anastrozole: 5 Key Benefits for Research tigative researcher approaches the Peptides in breast cancer therapy: From mechanisms to emerging molecule as a biochemical probe.
Furthermore, while some literature explores how anastrozole is an effective treatment for men dealing with elevated estrogen levels in specific clinical scenarios, laboratory research focuses on the fundamental mechanisms of the molecule itself. Researchers should remain aware that anastrozole is a nonsteroidal inhibitor of aromatase and that its experimental use should always be conducted in accordance with institutional biosafety and research protocols.
By maintaining a focus on the structural and functional properties of the molecule—such as its triazole-based binding affinity—scientists can continue to advance our understanding of aromatase inhibition without conflating laboratory-grade research materials with clinical applications.